MVP Medical Developments International Limited
Healthcare · Drug Manufacturers - Specialty & Generic
· website
$0.43
52wk 0.36 – 0.77
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Medical Developments International Limited
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$48.44M
P/E (trailing)
—
P/E (forward)
33.08
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
1.41
EV / EBITDA
20.49
Price / Book
0.88
ROE
-0.8%
Operating margin
3.2%
Net margin
-1.1%
Total cash
$16.88M
Total debt
$1.83M
Current ratio
6.07
Debt / Equity
0.03
Free cash flow
$1.49M
Avg volume
182,440
Latest annual results
(FY ending 30 Jun 2025)
- Revenue$39.06M
- Gross profit$29.43M
- Operating income-$1.76M
- Net income$94.00K
- Diluted EPS0.00
- Free cash flow-$1.08M
- Net debt-$15.85M